Lola Rodgers
Family · New York, NYNPI 1598284762
Payments from drug & device makers
Across 208 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$583
- AstraZeneca$576
- Boehringer Ingelheim$481
- Mylan Specialty L.p.$432
- Bayer$322
- Novo Nordisk$225
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,628100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 50 | $583 |
| AstraZeneca | 27 | $576 |
| Boehringer Ingelheim | 22 | $481 |
| Mylan Specialty L.p. | 20 | $432 |
| Bayer | 20 | $322 |
| Novo Nordisk | 15 | $225 |
| Viatris Specialty LLC | 4 | $111 |
| GSK | 6 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $101 |
| Neurocrine Biosciences, Inc. | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Novartis | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Dexcom, Inc. | 2 | $43 |
| AbbVie | 2 | $43 |
| Neurelis, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Johnson & Johnson | 2 | $29 |
| Medtronic | 2 | $28 |
| UCB, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| Abbott | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$3,628 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $9,709 |
| Levothyroxine Sodium | 66 | $790 |
| Mirtazapine | 41 | $767 |
| Sodium Chloride0.9 % Sodium Chloride | 58 | $656 |
| Potassium Chloride | 39 | $491 |
| Hydroxyzine Hcl | 33 | $417 |
| Lactulose | 22 | $388 |
| Famotidine | 28 | $308 |
| Furosemide | 42 | $289 |
| CeftriaxoneCeftriaxone Sodium | 18 | $278 |
| Azithromycin | 24 | $271 |
| Trazodone Hcl | 27 | $236 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 16 | $223 |
| Memantine Hcl | 11 | $201 |
| Primidone | 11 | $195 |
Paid to pharmacies, not to this prescriber.
Other family in New York
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Mary Sullivan-WhalenNew York$137K
- Leslie WoronaNew York$77K
- Thomas SaglimbeniNew York$48K
- Kathryn JohnsonNew York$48K
- Derek PinedaNew York$38K
- Rebecca SchoriNew York$32K
- Evangelia NezisNew York$22K
- Colette NelsonNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.